Armando Gabrielli

Author PubWeight™ 60.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013 5.99
2 Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006 4.46
3 Management of minor head injury in patients receiving oral anticoagulant therapy: a prospective study of a 24-hour observation protocol. Ann Emerg Med 2012 3.55
4 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013 3.11
5 Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 2009 2.51
6 Regional Implantation of Autologous Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients With Systemic Sclerosis. Cell Transplant 2014 2.02
7 Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. J Rheumatol 2002 1.97
8 Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002 1.81
9 Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 2007 1.60
10 Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care 2014 1.56
11 Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol 2012 1.41
12 Role of viral infections in the etiopathogenesis of systemic sclerosis. Clin Exp Rheumatol 2013 1.40
13 Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006 1.30
14 Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011 1.26
15 Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005 1.26
16 Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD. Blood 2013 1.24
17 Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One 2010 1.15
18 Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002 1.10
19 Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012 1.06
20 Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) 2012 1.06
21 Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. Autoimmun Rev 2010 1.03
22 Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. Chest 2015 1.01
23 Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005 0.99
24 Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev 2012 0.98
25 Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis. Arthritis Rheum 2011 0.90
26 Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Autoimmun Rev 2009 0.88
27 Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiol Dis 2006 0.87
28 Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Res Ther 2014 0.87
29 Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. Clin Exp Rheumatol 2011 0.86
30 Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. Clin Rheumatol 2014 0.85
31 CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment. Clin Exp Rheumatol 2012 0.84
32 Acute myocarditis associated with adenoviral infection in a patient with scleroderma. Clin Rheumatol 2003 0.82
33 From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature. Clin Rheumatol 2005 0.82
34 Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. Fibrogenesis Tissue Repair 2011 0.80
35 Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA. Immunology 2014 0.80
36 [Intravenous immunoglobulin treatment in autoimmune diseases]. Recenti Prog Med 2007 0.79
37 Stiff and tight skin: a rear window into fibrosis without inflammation. Sci Transl Med 2010 0.79
38 Role of the HLA class II: HCV-related disorders. Ann N Y Acad Sci 2007 0.79
39 Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb. J Biol Chem 2002 0.78
40 Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile. Curr Drug Saf 2016 0.77
41 Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance. Radiol Med 2014 0.76
42 Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. Arthritis Rheum 2009 0.76
43 Biomechanical study of 16-mm threaded, 32-mm threaded, and fully threaded SCFE screw fixation. J Pediatr Orthop 2011 0.76
44 Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. J Gen Virol 2009 0.76
45 Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'. Autoimmun Rev 2015 0.75
46 Reply to J. Magalon et al. Cell Transplant 2015 0.75
47 Pemphigus vulgaris is characterized by low IgG reactivities to specific self-antigens along with high IgG reactivity to desmoglein 3. Immunology 2014 0.75
48 Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. Hum Immunol 2002 0.75
49 [The diagnostic admission in an internal medicine service: clinical and economic aspects]. Recenti Prog Med 2007 0.75
50 [Immunosuppressant treatment in refractory myositis. Our experience]. Recenti Prog Med 2009 0.75
51 Subcutaneous immunoglobulins in ocular myositis. Rheumatology (Oxford) 2012 0.75
52 Breast contouring in postbariatric patients: a technique selection algorithm. Obes Surg 2010 0.75
53 Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile. Curr Drug Saf 2016 0.75